Yue Zhang

Dr. Yue Zhang

Qinghai University, Xining, Qinghai, China
orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2019 in Molecular & Cellular Proteomics
Verified
Journal Article
Open access
PDF file
DYDeqi Yin
Deqi Yin
NJNing Jiang
Ning Jiang
YZYue Zhang
Yue Zhang
DWDawei Wang
Dawei Wang
XSXiaoyu Sang
Xiaoyu Sang
QCQijun Chen
Qijun Chen
Toxoplasma gondii is a unicellular protozoan parasite of the phylum Apicomplexa. The parasite repeatedly goes through a cycle of invasion, division and induction of host cell rupture, which is an obligatory process for proliferation inside warm-blooded animals. It is known that the biology of the parasite is controlled by a variety of mechanisms ranging from genomic to epigenetic to transcriptional regulation. In this study, we investigated the global protein posttranslational lysine crotonylation and 2-hydroxyisobutyrylation of two T. gondii strains, RH and ME49, which represent distinct phenotypes for proliferation and pathogenicity in the host. Proteins with differential expression and modification patterns associated with parasite phenotypes were identified. Many proteins in T. gondii were crotonylated and 2-hydroxyisobutyrylated, and they were localized in diverse subcellular compartments involved in a wide variety of cellular functions such as motility, host invasion, metabolism and epigenetic gene regulation. These findings suggest that lysine crotonylation and 2-hydroxyisobutyrylation are ubiquitous throughout the T. gondii proteome, regulating critical functions of the modified proteins. These data provide a basis for identifying important proteins associated with parasite development and pathogenicity.

6 July 2024 in BMC Veterinary Research
Verified
Journal Article
Open access
PDF file
BLBingzhou Lu
Bingzhou Lu
YRYi Ru
Yi Ru
RHRongzeng Hao
Rongzeng Hao
YYYang Yang
Yang Yang
HLHuanan Liu
Huanan Liu
YCYan Cui
Yan Cui
Background: Foot-and-mouth disease (FMD) is a devastating disease affecting cloven-hoofed animals, that leads to significant economic losses in affected countries and regions. Currently, there is an evident inclination towards the utilization of nanoparticles as powerful platforms for innovative vaccine development. Therefore, this study developed a ferritin-based nanoparticle (FNP) vaccine that displays a neutralizing epitope of foot-and-mouth disease virus (FMDV) VP1 (aa 140–158) on the surface of FNP, and evaluated the immunogenicity and protective efficacy of these FNPs in mouse and guinea pig models to provide a strategy for developing potential FMD vaccines. Results: This study expressed the recombinant proteins Hpf, HPF-NE and HPF-T34E via an E. coli expression system. The results showed that the recombinant proteins Hpf, Hpf-NE and Hpf-T34E could be effectively assembled into nanoparticles. Subsequently, we evaluated the immunogenicity of the Hpf, Hpf-NE and Hpf-T34E proteins in mice, as well as the immunogenicity and protectiveness of the Hpf-T34E protein in guinea pigs. The results of the mouse experiment showed that the immune efficacy in the Hpf-T34E group was greater than the Hpf-NE group. The results from guinea pigs immunized with Hpf-T34E showed that the immune efficacy was largely consistent with the immunogenicity of the FMD inactivated vaccine (IV) and could confer partial protection against FMDV challenge in guinea pigs. Conclusions: The Hpf-T34E nanoparticles stand out as a superior choice for a subunit vaccine candidate against FMD, offering effective protection in FMDV-infected model animals. FNP-based vaccines exhibit excellent safety and immunogenicity, thus representing a promising strategy for the continued development of highly efficient and safe FMD vaccines.

11 April 2025 in Viruses
Verified
Journal Article
Open access
PDF file
YZYue Zhang
Yue Zhang
YRYi Ru
Yi Ru
LZLonghe Zhao
Longhe Zhao
RHRongzeng Hao
Rongzeng Hao
YYYang Yang
Yang Yang
HZHaixue Zheng
Haixue Zheng
Vaccination remains the most effective strategy for preventing infectious diseases. Subunit vaccines, which consist of antigenic components derived from pathogens, offer significant advantages in terms of biosafety, ease of preparation, and scalability. However, subunit vaccines often exhibit lower immunogenicity than whole-pathogen vaccines do. To address this limitation, coupling antigens with nanoparticles has emerged as a promising strategy for enhancing immune responses by mimicking pathogen structures and improving antigen presentation. This study evaluated the stability of ferritin (F-nps) and encapsulin (E-nps) nanoparticles and their efficient uptake by bone-marrow-derived dendritic cells (BMDCs) in vitro. In vivo studies demonstrated their effective targeting of lymph nodes. The African swine fever virus C129R protein was conjugated to ferritin and encapsulin nanoparticles to assess its ability to enhance antigen-specific immune responses. In murine models, both F-nps and E-nps significantly increased the immunogenicity of the C129R antigen, highlighting their potential as effective vaccine delivery systems. These findings underscore the promise of ferritin and encapsulin nanoparticles as delivery platforms for enhancing antigen immunogenicity and pave the way for the development of nanoparticle-based vaccines.

3 May 2025 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
YZYue Zhang
Yue Zhang
YRYi Ru
Yi Ru
LZLonghe Zhao
Longhe Zhao
RHRongzeng Hao
Rongzeng Hao
YYYang Yang
Yang Yang
HZHaixue Zheng
Haixue Zheng

27 June 2025 in ACS Biomaterials Science & Engineering
Verified
Journal Article
Closed access
YZYue Zhang
Yue Zhang
LZLonghe Zhao
Longhe Zhao
RHRongzeng Hao
Rongzeng Hao
YYYang Yang
Yang Yang
CSChaochao Shen
Chaochao Shen
HZHaixue Zheng
Haixue Zheng

Verified
Journal Article
Open access
PDF file
YZYue Zhang
Yue Zhang
YRYi Ru
Yi Ru
XLXiuping Li
Xiuping Li
GWGuanghua Wang
Guanghua Wang
YHYong Hu
Yong Hu
LMLiqing Ma
Liqing Ma
This review systematically evaluates research on self-assembling protein nanoparticles (SPNPs)-based vaccine, focusing on three major categories: virus-like particles (VLPs), natural protein nanoparticles (e.g., ferritin and encapsulin), and computationally designed protein nanoparticles—with comparative analyses of their design strategies, immunogenicity, and applicability in next-generation vaccines. VLPs can elicit robust humoral and cellular immune responses due to their virus-mimetic structures. Natural protein nanoparticles provide excellent biocompatibility and controllable self-assembly for multivalent antigen presentation. Artificially designed protein nanoparticles allow precise structural optimization to facilitate tailored antigen display and immune modulation. Overall, SPNPs constitute a versatile and powerful platform for vaccine development. By integrating natural and engineered design principles, they offer new opportunities for rational vaccine design and the development of safer and more effective immunization strategies.